Publicaciones en las que colabora con Jesus M. Prieto Valtueña (12)

2019

  1. The cirrhotic liver is depleted of docosahexaenoic acid (DHA), a key modulator of NF-κB and TGFβ pathways in hepatic stellate cells

    Cell Death and Disease, Vol. 10, Núm. 1

2018

  1. TMEM173 Alternative Spliced Isoforms Modulate Viral Replication through the STING Pathway

    ImmunoHorizons, Vol. 2, Núm. 11, pp. 363-376

2016

  1. Insulin-like growth factor I (IGF-I) expressed from an AAV1 vector leads to a complete reversion of liver cirrhosis in rats

    PLoS ONE, Vol. 11, Núm. 9

2012

  1. AAV vectors transduce hepatocytes in vivo as efficiently in cirrhotic as in healthy rat livers

    Gene Therapy, Vol. 19, Núm. 4, pp. 411-417

2010

  1. Insulin-like growth factor i gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats

    Hepatology, Vol. 51, Núm. 3, pp. 912-921

2006

  1. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning

    Journal of Experimental Medicine, Vol. 203, Núm. 13, pp. 2809-2815

  2. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing

    Journal of Virology, Vol. 80, Núm. 24, pp. 12236-12247

  3. Low surface expression of B7-1 (CD80) is an immunoescape mechanism of colon carcinoma

    Cancer Research, Vol. 66, Núm. 4, pp. 2442-2450

2005

  1. Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells

    Molecular Therapy, Vol. 12, Núm. 5, pp. 950-959

2004

  1. Factors influencing the production of recombinant SV40 vectors

    Molecular Therapy, Vol. 10, Núm. 4, pp. 780-791

2003

  1. In vitro and in vivo comparative study of chimeric liver-specific promoters

    Molecular Therapy, Vol. 7, Núm. 3, pp. 375-385

  2. Inhibiting expression of specific genes in mammalian cells with 5′ end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-MRNA

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, Núm. 14, pp. 8264-8269